Invasive strategy did not improve long-term outcome in non-STEMI with comorbidities.
A tendency towards a better outcome in the short-term was observed.
Comorbidities should not dissuade the invasive management in non-STEMI.
The fact that mid and long term outcomes remained unmodified must be kept in mind.